Literature DB >> 33872678

Extracorporeal membrane oxygenation combined with sequential blood purification in the treatment of myocardial damage and cardiac arrest caused by mushroom poisoning.

Yang Li1, Zhiqiang Qiu1, Liang Huang1, Chunshui Cao2.   

Abstract

Mushroom poisoning is a common clinical problem. Severe mushroom poisoning often causes liver and kidney failure. Although severe myocardial damage is rare, the fatality rate is extremely high. This case report describes a 56-year-old male suffered severe myocardial damage, multiple organ dysfunction, circulatory failure, recurrent malignant arrhythmia, and cardiac arrest after the ingestion of wild mushrooms. He was administered venoarterial extracorporeal membrane oxygenation (VA-ECMO) combined with hemoperfusion, plasma exchange and continuous renal replacement therapy. The heart rhythm gradually stabilized 3 hours after ECMO surgery. On the 6th day after ECMO, heart function recovered. The patient was then weaned from ECMO, and he ultimately recovered and was discharged. In patients with fatal mushroom poisoning leading to refractory arrhythmia and cardiac arrest, early implementation of VA-ECMO combined with sequential blood purification treatment can improve the prognosis and increase the survival rate.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  ECMO; cardiac arrest; mushroom poisoning; myocardial damage; sequential blood purification

Year:  2021        PMID: 33872678     DOI: 10.1016/j.toxicon.2021.04.011

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

Review 1.  Mechanism and treatment of α-amanitin poisoning.

Authors:  Jinfang Xue; Xiran Lou; Deyuan Ning; Ruifei Shao; Guobing Chen
Journal:  Arch Toxicol       Date:  2022-10-21       Impact factor: 6.168

2.  Effect of Four-in-One Optimized Emergency Nursing Procedure on Symptoms and Vital Signs of Patients with Mushroom Poisoning.

Authors:  Suling Li; Kunyu Liu; Zhenning Liu; Yu Wang
Journal:  J Healthc Eng       Date:  2022-03-31       Impact factor: 2.682

Review 3.  Hemoperfusion: technical aspects and state of the art.

Authors:  Claudio Ronco; Rinaldo Bellomo
Journal:  Crit Care       Date:  2022-05-12       Impact factor: 19.334

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.